Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Oct 21, 2024
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Award
Common Stock Options
2024-10-08+250,000→ 831,544 totalExercise: $2.45From: 2024-10-08Exp: 2029-10-08→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Not applicable.
- [F2]The securities listed in Table II are securities owned directly by Dr. Salkind and his wife and by a family trust.
- [F3]Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share, (iv) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share.